Soundbite Medical Solutions has announced that the US Patent and Trademark Office has issued a patent to a device for delivering high amplitude broadband mechanical pulses to treat a lesion present in a blood vessel. The device includes a catheter body, an inflatable balloon and at least one mechanical waveguide connected to a source of high amplitude broadband mechanical pulses for propagating the pulses to the lesion. The patent protects novel Soundbite Active Balloon devices, intended for plaque modification of calcified arteries. This is the fifth US patent to be issued around the Soundbite technology, further solidifying, and broadening the scope of protection for the company’s technology platform. The patent allows Soundbite to compete in the plaque modification space with a broader array of active devices addressing a larger market and clinical challenge. Calcification is a dominant hallmark of advanced atherosclerotic disease and is often underestimated and under-treated. Problematic calcium in the form of stenosis and chronic total occlusions (CTOs) are encountered frequently in patients with both coronary and peripheral artery disease. “Building our patent portfolio to address complex calcium is a testament to our highly talented engineering team. The pursuit of excellence in serving our patients with clinical solutions begins with medical devices that are unique, differentiated, and of the highest quality. Protecting that work while innovating to meet the growing challenges inherent in calcific occlusive disease will establish Soundbite as a leader in its field,” said Lori Chmura, president and CEO of Soundbite. The post Soundbite Medical gains fifth US patent for its plaque modification technology appeared first on Vascular News.